Comparison
Why is 180 Life Sciences Corp. ?
- Poor long term growth as Net Sales has grown by an annual rate of -1.00% and Operating profit at -329.35% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -6.60
- INTEREST(HY) At USD 0.32 MM has Grown at 1,372.17%
- OPERATING CASH FLOW(Y) Lowest at USD -19.36 MM
- OPERATING PROFIT(Q) Lowest at USD -220.49 MM
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -73.74%, its profits have risen by 71%
- Along with generating -73.74% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is 180 Life Sciences Corp. for you?
High Risk, High Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at -96.7%
Fallen by 0% (YoY
Higher at USD 4.11 MM
Highest at USD 561.12 MM
Highest at 107.09 times
At USD 0.32 MM has Grown at 1,372.17%
Lowest at USD -19.36 MM
Lowest at USD -220.49 MM
Lowest at USD -219.87 MM
Lowest at USD -219.87 MM
Here's what is working for 180 Life Sciences Corp.
Net Sales (USD MM)
Cash and Cash Equivalents
Debtors Turnover Ratio
Net Sales (USD MM)
Raw Material Cost as a percentage of Sales
Here's what is not working for 180 Life Sciences Corp.
Interest Paid (USD MM)
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
Operating Cash Flows (USD MM)
Operating Profit (USD MM)
Pre-Tax Profit (USD MM)
Net Profit (USD MM)






